Publication not explained
Read the Original
This page is a summary of: Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer, OncoTargets and Therapy, December 2015, Taylor & Francis, DOI: 10.2147/ott.s68558.
You can read the full text:
Be the first to contribute to this page